fda glp-1 warning letters september 2025 news sends letter after Chinese supplier breaks import restrictions Novo Hit With FDA Warning

See FAQ section for BMI calculation and additional requirements

Although GLP-1 drug manufacturers agreed to a $245 net price, a substantial discount off prevailing list prices, savings to plans from a lower price may have been insufficient to offset higher costs associated with an uptake in GLP-1 use for obesity treatment

At Boca Medical Care, we are committed to assisting you on your wellness journey

Behind the Jingle: The Reality of Staffing GLP-1 Clinical Trials A coffee chat with Tom Murn on what it takes to staff the next wave of clinical research

Conflict of interest JR-F declares that he has received honoraria for lectures for AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Lilly, Sanofi, Novartis, Abbvie, Merck, and Bayer

10.1186/s12933-024-02461-2 11 ChenD.LiangH.HuangL.ZhouH.WangZ